TVRD

NASD Tvardi Therapeutics Inc.
Oct 17, 2026 · 8:11 PM ET EOD Market Closed

$1.01 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.01, $0.06 below the day’s high of $1.07

YTD change
-76.51%
vs 20-day SMA
-16.91%
vs 200-day SMA
-65.69%

Price ranges

Previous day
$1.00 $1.07
open $1.05 close $1.01
-$0.04 (-3.81%)
Today
$1.00 $1.07
$1.01
Past week
$0.97 $1.09
from $1.08 now $1.01
-$0.07 (-6.48%)
Past month
$0.93 $1.73
from $1.62 now $1.01
-$0.61 (-37.65%)
This year
$0.93 $5.69
from $4.30 now $1.01
-$3.29 (-76.51%)

Price & Performance

-2.38 (-70.21%) / 6M

$0.6800$2.23$3.77$5.32Apr 17Jul 20Oct 16

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.7% away from all-time highs of $43.65
  • TVRD is down 77% since the beginning of the year
  • TVRD is down 84% over the past 12 months
  • TVRD is down 38% over the past 1 month
  • 3% of all TVRD investors are betting against TVRD

TVRD reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -84.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.69
Earnings momentum -26.6% Quarterly EPS growth
Quarterly change -26.6%

Valuation

P/E ratio N/A
Enterprise value $-5581960.0
Beta -0.48

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$15.8M
Debt$145.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $13.5M

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $33.35 +2.30%
ARGX argenx SE Sponsored ADR $819.14 -3.21%
ONC BeOne Medicines Ltd. Sponsored ADR $369.06 -1.34%
WXIBF Wuxi Biologics (Cayman) Inc. $6.36 +2.66%
INCY Incyte Corporation $113.07 -0.18%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.